Therefore, further exploration of the regulatory mechanism between the PI3K/Akt signaling pathway and p53 could help researchers elucidate the pathogenesis of IDD and develop new therapeutic approaches. This evidence concerns the gene TP53 and intervertebral disk degenerative disorder.